Biodesix Inc. (BDSX) Misses Q3 EPS by 110c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BDSX Hot Sheet
Join SI Premium – FREE
Biodesix Inc. (NASDAQ: BDSX) reported Q3 EPS of ($1.16), $1.10 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $21.8 million versus the consensus estimate of $20.83 million.
For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BillionToOne, Inc. (BLLN) Tops Q3 EPS by 23c; Offers Guidance
- PureCycle Technologies, Inc. (PCT) Tops Q3 EPS by 25c
- ACRES Commercial Realty (ACR) Misses Q3 EPS by 526c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
